Try our Advanced Search for more refined results

Alleged Insider Trader Sues For Fees In Del. Bioverativ Suit

By Leslie A. Pappas ( December 15, 2022, 2:07 PM EST) -- A former board member of Bioverativ Inc., a hemophilia-focused biopharm that Sanofi SA bought in 2018, has sued both companies in Delaware Chancery Court, alleging they have refused to pay his legal fees in an ongoing shareholder suit accusing him of insider trading ahead of the $11.6 billion merger....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!